Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart

Basic Research in Cardiology

Volumn 111, Issue 1, 2016, Pages 1-12

  Perjés, Ábel ^a,b   Kilpiö, Teemu ^a   Ulvila, Johanna ^a   Magga, Johanna ^a   Alakoski, Tarja ^a   Szabó, Zoltán ^a   Vainio, Laura ^a   Halmetoja, Eveliina ^a   Vuolteenaho, Olli ^a   Petäjä Repo, Ulla ^a   Szokodi, István ^b   Kerkelä, Risto ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Apela; Cardiovascular; Cell signaling; Contractility; Extracellular signal regulated kinase (ERK); G protein coupled receptor (GPCR); Heart failure; Myocardial infarction; Peptides

Indexed keywords

APELIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE; APLNR PROTEIN, MOUSE; APLNR PROTEIN, RAT; SIGNAL PEPTIDE;

ADULT; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE REMODELING; INOTROPISM; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; TODDLER; UPREGULATION; WESTERN BLOTTING; ZEBRA FISH; AGING; ANIMAL; CARDIAC MUSCLE; DISEASE MODEL; HEART; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

AGING; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; HEART; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84948415602     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-015-0521-6     Document Type: Article

References (44)

1. Chamberland C, Barajas-Martinez H, Haufe V, Fecteau M-H, Delabre J-F, Burashnikov A, Antzelevitch C, Lesur O, Chraibi A, Sarret P, Dumaine R (2010) Modulation of canine cardiac sodium current by Apelin. J Mol Cell Cardiol 48:694–701. doi:10.1016/j.yjmcc.2009.12.011
2. Charo DN, Ho M, Fajardo G, Kawana M, Kundu RK, Sheikh AY, Finsterbach TP, Leeper NJ, Ernst KV, Chen MM, Ho YD, Chun HJ, Bernstein D, Ashley EA, Quertermous T (2009) Endogenous regulation of cardiovascular function by apelin-APJ. Am J Physiol Heart Circ Physiol 297:1904–1913. doi:10.1152/ajpheart.00686.2009
3. Chen MM, Ashley EA, Deng DXF, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, Fowler M, Robbins R, Johnson FL, Bruhn L, McDonagh TA, Dargie HJ, Yakhini Z, Tsao PS, Quertermous T (2003) Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 108:1432–1439. doi:10.1161/01.CIR.0000091235.94914.75
4. Chng SC, Ho L, Tian J, Reversade B (2013) ELABELA: a hormone essential for heart development signals via the apelin receptor. Dev Cell 27:672–680. doi:10.1016/j.devcel.2013.11.002
5. Chong KS, Gardner RS, Morton JJ, Ashley EA, McDonagh TA (2006) Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. Eur J Heart Fail 8:355–360. doi:10.1016/j.ejheart.2005.10.007
6. D’Aniello C, Lonardo E, Iaconis S, Guardiola O, Liguoro AM, Liguori GL, Autiero M, Carmeliet P, Minchiotti G, Aniello CD, Maria A (2009) G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway. Circ Res 105:231–238. doi:10.1161/CIRCRESAHA.109.201186
7. Dai T, Ramirez-Correa G, Gao WD (2006) Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553:222–228. doi:10.1016/j.ejphar.2006.09.034
8. Deng C, Chen H, Yang N, Feng Y, Hsueh AJW (2015) Apela regulates fluid homeostasis by binding to the APJ receptor to activate Gi signaling. J Biol Chem 290:18261–18268. doi:10.1074/jbc.M115.648238
9. Dorn GW, Souroujon MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu G, Lorenz JN, Mochly-Rosen D (1999) Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci 96:12798–12803. doi:10.1073/pnas.96.22.12798
10. Falcão-Pires I, Gonçalves N, Henriques-Coelho T, Moreira-Gonçalves D, Roncon-Albuquerque R, Leite-Moreira AF (2009) Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 296:H2007–H2014. doi:10.1152/ajpheart.00089.2009
11. Földes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, Mäyränpää M, Sármán B, Seres L, Skoumal R, Lakó-Futó Z, DeChâtel R, Ruskoaho H, Tóth M, Foldes G (2003) Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 308:480–485. doi:10.1016/S0006-291X(03)01424-4
12. Gao E, Lei YH, Shang X, Huang ZM, Zuo L, Boucher M, Fan Q, Chuprun JK, Ma XL, Koch WJ (2010) A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 107:1445–1453. doi:10.1161/CIRCRESAHA.110.223925
13. Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674–699. doi:10.1161/CIRCRESAHA.116.305348
14. Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet 383:1933–1943. doi:10.1016/S0140-6736(14)60107-0
15. Inui M, Fukui A, Ito Y, Asashima M (2006) Xapelin and Xmsr are required for cardiovascular development in Xenopus laevis. Dev Biol 298:188–200. doi:10.1016/j.ydbio.2006.06.028
16. Iwanaga Y, Kihara Y, Takenaka H, Kita T (2006) Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 41:798–806. doi:10.1016/j.yjmcc.2006.07.004
17. Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J, Johnston NR, Denvir MA, Megson IL, Flapan AD, Newby DE (2010) Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation 121:1818–1827. doi:10.1161/CIRCULATIONAHA.109.911339
18. Kaikkonen L, Magga J, Ronkainen V-P, Koivisto E, Perjes A, Chuprun JK, Vinge LE, Kilpiö T, Aro J, Ulvila J, Alakoski T, Bibb JA, Szokodi I, Koch WJ, Ruskoaho H, Kerkelä R (2014) p38α regulates SERCA2a function. J Mol Cell Cardiol 67:86–93. doi:10.1016/j.yjmcc.2013.12.005
19. Kang Y, Kim J, Anderson JP, Wu J, Gleim SR, Kundu RK, McLean DL, Kim J-D, Park H, Jin S-W, Hwa J, Quertermous T, Chun HJ (2013) Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development. Circ Res 113:22–31. doi:10.1161/CIRCRESAHA.113.301324
20. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O, Fujino M (2001) Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538:162–171. doi:10.1016/S0167-4889(00)00143-9
21. Kehat I, Davis J, Tiburcy M, Accornero F, Saba-El-Leil MK, Maillet M, York AJ, Lorenz JN, Zimmermann WH, Meloche S, Molkentin JD (2011) Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ Res 108:176–183. doi:10.1161/CIRCRESAHA.110.231514
22. Kerkelä R, Karsikas S, Szabo Z, Serpi R, Magga J, Gao E, Alitalo K, Anisimov A, Sormunen R, Pietilä I, Vainio L, Koch WJ, Kivirikko KI, Myllyharju J, Koivunen P (2013) Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection. Mol Cell Biol 33:3321–3329. doi:10.1128/MCB.00432-13
23. Kinnunen P, Szokodi I, Nicholls MG, Ruskoaho H (2000) Impact of NO on ET-1-and AM-induced inotropic responses: potentiation by combined administration. Am J Physiol Regul Integr Comp Physiol 279:R569–R575
24. Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, Leschnik M, Leibbrandt A, Markovic M, Makovic M, Schwaighofer J, Beetz N, Musialek R, Neely GG, Komnenovic V, Kolm U, Metzler B, Ricci R, Hara H, Meixner A, Nghiem M, Chen X, Dawood F, Wong KM, Sarao R, Cukerman E, Kimura A, Hein L, Thalhammer J, Liu PP, Penninger JM (2007) Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res 101:e32–e42. doi:10.1161/CIRCRESAHA.107.158659
25. Li M, Gou H, Tripathi BK, Huang J, Jiang S, Dubois W, Waybright T, Lei M, Shi J, Zhou M, Huang J (2015) An Apela RNA-containing negative feedback loop regulates p53-mediated apoptosis in embryonic stem cells. Cell Stem Cell 16:669–683. doi:10.1016/j.stem.2015.04.002
26. Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouysségur J, Pagès G, De Windt LJ, Doevendans PA, Molkentin JD (2004) MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109:1938–1941. doi:10.1161/01.CIR.0000127126.73759.23
27. El Messari S, Iturrioz X, Fassot C, De Mota N, Roesch D, Llorens-Cortes C (2004) Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. J Neurochem 90:1290–1301. doi:10.1111/j.1471-4159.2004.02591.x
28. O’Dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR, Nguyen T (1993) A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136:355–360
29. Omland T, Aakvaag A, Bonarjee VVS, Caidahl K, Lie RT, Nilsen DWT, Sundsfjord JA, Dickstein K (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-Terminal proatrial natriuretic peptide. Circulation 93:1963–1969. doi:10.1161/01.CIR.93.11.1963
30. Pauli A, Norris ML, Valen E, Chew G-L, Gagnon JA, Zimmerman S, Mitchell A, Ma J, Dubrulle J, Reyon D, Tsai SQ, Joung JK, Saghatelian A, Schier AF (2014) Toddler: an embryonic signal that promotes cell movement via Apelin receptors. Science 343:1248636. doi:10.1126/science.1248636
31. Perjés Á, Kubin A-M, Kónyi A, Szabados S, Cziráki A, Skoumal R, Ruskoaho H, Szokodi I (2012) Physiological regulation of cardiac contractility by endogenous reactive oxygen species. Acta Physiol 205:26–40. doi:10.1111/j.1748-1716.2011.02391.x
32. Perjés Á, Skoumal R, Tenhunen O, Kónyi A, Simon M, Horváth IG, Kerkelä R, Ruskoaho H, Szokodi I (2014) Apelin increases cardiac contractility via protein kinase Cε- and extracellular signal-regulated kinase-dependent mechanisms. PLoS One 9:e93473. doi:10.1371/journal.pone.0093473
33. Scimia MC, Hurtado C, Ray S, Metzler S (2012) APJ acts as a dual receptor in cardiac hypertrophy. Nature 488:394–398. doi:10.1038/nature11263
34. Scott IC, Masri B, D’Amico LA, Jin S-W, Jungblut B, Wehman AM, Baier H, Audigier Y, Stainier DYR (2007) The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell 12:403–413. doi:10.1016/j.devcel.2007.01.012
35. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CCT (2007) Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury. Basic Res Cardiol 102:518–528. doi:10.1007/s00395-007-0671-2
36. Szabó Z, Magga J, Alakoski T, Ulvila J, Piuhola J, Vainio L, Kivirikko KI, Vuolteenaho O, Ruskoaho H, Lipson KE, Signore P, Kerkelä R (2014) Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload—induced heart failure. Hypertension 63:1235–1240. doi:10.1161/HYPERTENSIONAHA.114.03279
37. Szokodi I, Kerkelä R, Kubin A-M, Sármán B, Kónyi A, Horváth IG, Papp L, Tóth M, Skoumal R, Ruskoaho H (2008) Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility. Circulation 118:1651–1658. doi:10.1161/CIRCULATIONAHA.107.758623
38. Szokodi I, Kinnunen P, Tavi P, Weckström M, Tóth M, Ruskoaho H (1998) Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation 97:1062–1070
39. Szokodi I, Tavi P, Földes G, Voutilainen-Myllylä S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysä J, Tóth M, Ruskoaho H (2002) Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91:434–440. doi:10.1161/01.RES.0000033522.37861.69
40. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251:471–476. doi:10.1006/bbrc.1998.9489
41. Wang W, McKinnie SMK, Patel VB, Haddad G, Wang Z, Zhabyeyev P, Das SK, Basu R, McLean B, Kandalam V, Penninger JM, Kassiri Z, Vederas JC, Murray AG, Oudit GY (2013) Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues. J Am Heart Assoc 2:e000249. doi:10.1161/JAHA.113.000249
42. Wang Z, Yu D, Wang M, Wang Q, Kouznetsova J, Yang R, Qian K, Wu W, Shuldiner A, Sztalryd C, Zou M, Zheng W, Gong D-W (2015) Elabela-apelin receptor signaling pathway is functional in mammalian systems. Sci Rep 5:8170. doi:10.1038/srep08170
43. Yang P, Maguire JJ, Davenport AP (2015) Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system. Trends Pharmacol Sci 36:560–567. doi:10.1016/j.tips.2015.06.002
44. Zeng X-XI, Wilm TP, Sepich DS, Solnica-Krezel L (2007) Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev Cell 12:391–402. doi:10.1016/j.devcel.2007.01.011